Author Archive

Fauci in the Hot-Seat While Other Culprits Go Free

Government bureaucrat Dr. Anthony Fauci has abused his power since beginning his career with NIAID in 1984.  He has directly influenced medicine and health policy world wide yet has never actually treated a patient since his initial four year internship and residency.

Some of his other crimes are:

But, it’s important to remember that while he was certainly complicit and at the very least agreed to and promoted destructive decisions knowing they would yield unprecedented chaos and ruin, along with Francis Collins, Rochelle Walensky, and many, many others, the National Security Council (NSC) was OZ behind the curtain.  This group advises the President on matters of national security – you know, people who advise about war and terrorism.

Ponder this fact for a moment.

War and terrorism.  Not public health.  
This should reframe everything in a quick hurry.

As noted by Debbie Lerman, nobody’s asking the right questions of the right people.  

Regarding the anti-scientific 6ft social distancing rule, it was based on the NSC’s lockdown-until-‘vaccine’ policy, meant to keep everyone terrified and isolated until the application of the miraculous mRNA ‘countermeasures’.

On March 19, 2020 FEMA assumed the lead for the federal response to COVID which was unannounced, unprecedented, and Lerman believes to be illegal. Formerly, and by law, HHS has been designated as Lead Federal Agency for pandemic responses in every document leading up to COVID until FEMA took over, whose parent agency is the Department of Homeland Security (DHS).  

As noted by Lerman, Dr. McCormick in the video below, and so many others, ALL the directives given by talking heads from public health agencies was not based on actual science or public health policy.  

http://  Approx. 6 Min

Dr. McCormick Rips Fauci a New One

June 4, 2024

In the most recent Circus act, I mean Congressional hearings, Representative Rich McCormick, who is a decorated veteran and ER physician who treated COVID patients from beginning to end, had much to say to Dr. Anthony Fauci about his mishandling of the ‘pandemic,’ and the fact it will have have devastating effects far into the future.

“It’s been proven that if you make it difficult for people in their lives, they lose their ideological bull-shit and they get vaccinated.”  ~ Dr. Anthony Fauci

“Everything I was censored on, I was proven to be right.” ~ Dr. McCormick

It is frightening that so many doctors, politicians, and leaders walked in lock-step behind absurd edicts which not only included peddling a brand-new, never used in humans mRNA gene therapy injection, as well as dangerous, ineffective drugs, including drugs used for lethal injection to treat COVID patients by sedating them for mechanical ventilation, both of which proved to be death sentences.

Dr. Mike Yeadon recently stated that 3 years worth of midazolam was used in a matter of weeks in the UK.

Then there’s the unprecedented vilification and cruelty of anyone who refused the clot shots, which is still going on – particularly by WHO Director-General Dr. Tedros Adhanom Ghebreyesus.

Fauci is guilty of many, many things but so are others.

For a well written article on the cruel loss of reason in the medical community: https://www.midwesterndoctor.com/p/the-price-of-truth-vs-deception-in

Go here to listen to Dr. Jay Battacharya professor of health policy at Stanford University, co-author of the Great Barrington Declaration, and a plaintiff in Murthy v. Missouri, a landmark free speech case against the Biden Administration who states that the catastrophic response during COVID will happen again until there’s an explicit repudiation of the doctrine by ‘public health.’

“The International Health Regulations and the WHO treaty are a way to essentially institutionalize this paradigm of how to manage pandemics going forward. You can’t have a Sweden next time that bucks the agenda.”  ~ Dr. Jay Battacharya

And for a bigger picture of why this all matters: https://madisonarealymesupportgroup.com/2024/05/21/rats-jumping-ship-covid-cover-up-uns-secret-plan-schwab-steps-down/

Category:

Activism, vaccines, Viruses

Vaccine Hesitancy in Lyme Borreliosis; Lancet Infectious Diseases

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/32649858?

Vaccination hesitancy in Lyme borreliosis; The Lancet Infectious Diseases

Carl Tuttle
Hudson, NH, United States
Jun 2, 2024

Please see the complaint below addressed to the Editor-in-Chief, The Lancet Infectious Diseases…

-Carl Tuttle

———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: u.hofer@lancet.com
Cc: marco.deambrogi@lancet.com, saleha.hassan@lancet.com, infectiousdiseases@lancet.com, ombudsperson@lancet.com, weboffice@lancet.com, editorial@lancet.com, cope_assistant@publicationethics.org, raymond_dattwyler@nymc.edu, paul_arnaboldi@nymc.edu
Date: 06/02/2024 12:04 PM EDT
Subject: Challenges to the publishing ethics of the journal—eg, conflicts of interest

The Lancet Infectious Diseases

Vaccination hesistancy in Lyme borreliosis
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00221-4/abstract

Raymond J Dattwyler, Paul M Arnaboldi

Published:May 31, 2024

“Although most patients respond well to appropriate antibiotic treatment, a subpopulation of individuals has ongoing symptoms after treatment. The cause of this post-treatment syndrome remains undefined.”  – Raymond J Dattwyler

June 2, 2024

The Lancet Group
125 London Wall
London, EC2Y 5AS, UK
Attn: Ursula Hofer, Editor-in-Chief, The Lancet Infectious Diseases

Dear Dr. Hofer,

Dr. Raymond Dattwyler owns 24 patents for Lyme disease that include diagnostic testing and vaccines both live bacteria and oral. How is this not a conflict of interest when publishing on the subject of vaccination in Lyme borreliosis?

Please correct the COI statement on Dattwyler’s publication.

As someone who has published on the subject of “Bacterial longevity” and “Outgrowing antibiotic action,” you may want to ask Dr. Dattwyler why he has not responded to my 2023 inquiry below:

Respectfully submitted,
Carl Tuttle
Independent Researcher
Hudson, NH USA

Cc: Iratxe Puebla, Facilitation and Integrity Officer
Committee on Publication Ethics (COPE)

Inquiry to Dr. Raymond Dattwyler:

———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: Raymond_Dattwyler@nymc.edu
Cc: npjvaccines@nature.com, abarrett@utmb.edu, R.W.Titball@exeter.ac.uk, mgomesso@uthsc.edu
Date: 01/06/2023 2:46 PM EST
Subject: The year that shaped the outcome of the OspA vaccine for human Lyme disease

npj Vaccines Jan 2022

The year that shaped the outcome of the OspA vaccine for human Lyme disease
https://www.nature.com/articles/s41541-022-00429-5

Raymond J. Dattwyler & Maria Gomes-Solecki

Department of Microbiology and Immunology
New York Medical College
Valhalla, NY
Raymond J. Dattwyler, Corresponding Author

Dear Dr. Dattwyler,

I read your manuscript with great interest as you call attention to a treatment-resistant Lyme arthritis with “no evidence of DNA” found in the joints of patients after antibiotic treatment.

For some strange reason however, I could not find the following 1995 publication within your paper identifying treatment-resistant neuroborreliosis:

European Neurology 1995

Seronegative Chronic Relapsing Neuroborreliosis
https://www.karger.com/Article/Abstract/117104

Lawrence C., Lipton R.B., Lowy F.D., Coyle P.K.d

Abstract

We report an unusual patient with evidence of Borrelia burgdorferi infection who experienced repeated neurologic relapses despite aggressive antibiotic therapy. Each course of therapy was associated with a Jarisch-Herxheimer-like reaction. Although the patient never had detectable free antibodies to B. burgdorferi in serum or spinal fluid, the CSF was positive on multiple occasions for complexed anti-B. burgdorferi antibodies, B. burgdorferi nucleic acids and free antigen.

In fact, Dr. Dattwyler there seems to be a great deal of “treatment-resistant” evidence published in multiple journals over the past three decades:
 
Peer Reviewed Evidence of Persistence of Lyme Disease Spirochete Borrelia burgdorferi and Tick-Borne Diseases (700 References)
https://www.dropbox.com/s/n09sk90eo6xz7ua/700%20articles%20LYME%20EvidenceofPersistence-V2.pdf?dl=0

So that brings me to the reason for this email…

Question:

Does a chronic relapsing seronegative disease fit the vaccine model? If not, would that, in and of itself, be the hidden reason for denying chronic (treatment-resistant) Lyme disease for almost three decades? In other words, patent royalties and pharmaceutical profits over lifesaving care?
 
A response to this inquiry is requested.

Carl Tuttle
Hudson, NH

Cc: Alan D.T. Barrett, PhD Editor-in-Chief

Rick Titball, PhD, DSc, Deputy Editor

Letter to the Editor of the BMJ published June 2020
https://www.bmj.com/content/369/bmj.m1041/rr-1

_______________

For the latest Lyme disease ‘vaccine’ candidates:  https://www.precisionvaccinations.com/vaccines/lyme-disease-vaccines

Category:

Activism, Lyme, vaccines

Major Collaborative Study: Effectiveness Data Shows No Benefit & 100% of Myocarditis in Kids is From COVID shots & New Rat Study

https://popularrationalism.substack.com/p/do-not-pass-this-by-major-collaborative?

DO NOT PASS THIS BY… MAJOR COLLABORATIVE STUDY FINDS ALL RISK AND NO BENEFIT – STUDY SHOWS 100% OF MYOCARDITIS IN KIDS IS FROM COVID19 SHOTS. MEANWHILE, EFFECTIVENESS DATA SHOW NO BENEFIT TO KIDS.

Study Links COVID-19 mRNA Shots, Not Infection to Heart Failure in Children. This MASSIVE study also shows no benefit in reduction of infection.

 
JAMES LYONS-WEILER
JUN 03, 2024
 

ACTION ITEM: CONTACT THE FDA AND DEMAND THEY PREVENT ALL CHILDREN FROM GETTING THESE INJECTIONS. LET THEM KNOW – ENOUGH IS ENOUGH.

A groundbreaking study by researchers from Oxford, Leeds, Harvard, and Bristol has confirmed that myocarditis and pericarditis only appear in children and adolescents following COVID-19 vaccination, not after infection. This extensive research analyzed official government data from over 1 million English children and adolescents, comparing vaccinated and unvaccinated subjects aged 5-11 and 12-15.

Key findings include:

  • All cases of myocarditis and pericarditis during the study period occurred in vaccinated individuals.

  • Most myocarditis and pericarditis cases were recorded after the first dose of the vaccine.

  • Hospitalizations related to COVID-19 were extremely rare among children and adolescents.

  • Over 50% of children who had myocarditis following the shot required hospitalization.

Read the full study here for more detailed insights.  (See link for article, study, and to contact the FDA)

_______________

Remember that Aldén et al has been highly censored but critical to understand.  Reverse transcription of mRNA, inserting the foreign code into human DNA has been one of the greatest fears during the mass, indiscriminate ‘vaccination’ campaign.  Go here to watch Dr. Peter McCullough discuss how getting the Pfizer or Moderna COVID-19 shot may be permanent for the vaccinated and their progeny. 

And now this……

https://link.springer.com/article/10.1007/s11064-023-04089-2

Prenatal Exposure to COVID-19 mRNA Vaccine BNT162b2 Induces Autism-Like Behaviors in Male Neonatal Rats: Insights into WNT and BDNF Signaling Perturbations

  • Open access
  • Published: Volume 49, pages 1034–1048, (2024)
Download PDF
Neurochemical ResearchAims and scopeSubmit manuscript

Prenatal Exposure to COVID-19 mRNA Vaccine BNT162b2 Induces Autism-Like Behaviors in Male Neonatal Rats: Insights into WNT and BDNF Signaling Perturbations
 

Abstract

The COVID-19 pandemic catalyzed the swift development and distribution of mRNA vaccines, including BNT162b2, to address the disease. Concerns have arisen about the potential neurodevelopmental implications of these vaccines, especially in susceptible groups such as pregnant women and their offspring. This study aimed to investigate the gene expression of WNT, brain-derived neurotrophic factor (BDNF) levels, specific cytokines, m-TOR expression, neuropathology, and autism-related neurobehavioral outcomes in a rat model. Pregnant rats received the COVID-19 mRNA BNT162b2 vaccine during gestation. Subsequent evaluations on male and female offspring included autism-like behaviors, neuronal counts, and motor performance. Molecular techniques were applied to quantify WNT and m-TOR gene expressions, BDNF levels, and specific cytokines in brain tissue samples. The findings were then contextualized within the extant literature to identify potential mechanisms. Our findings reveal that the mRNA BNT162b2 vaccine significantly alters WNT gene expression and BDNF levels in both male and female rats, suggesting a profound impact on key neurodevelopmental pathways. Notably, male rats exhibited pronounced autism-like behaviors, characterized by a marked reduction in social interaction and repetitive patterns of behavior. Furthermore, there was a substantial decrease in neuronal counts in critical brain regions, indicating potential neurodegeneration or altered neurodevelopment. Male rats also demonstrated impaired motor performance, evidenced by reduced coordination and agility. Our research provides insights into the effects of the COVID-19 mRNA BNT162b2 vaccine on WNT gene expression, BDNF levels, and certain neurodevelopmental markers in a rat model. More extensive studies are needed to confirm these observations in humans and to explore the exact mechanisms. A comprehensive understanding of the risks and rewards of COVID-19 vaccination, especially during pregnancy, remains essential.

_____________

 

Category:

Activism, Autism, Heart Issues, research, vaccines, Viruses

Interview with Lyme Literate Doctor Kenneth Liegner

https://lymediseaseassociation.org/blogs/lda-guest-blogs/may-awareness-guest-blog-an-interview-with-kenneth-liegner-md/

May Awareness LDA Guest Blogger

Interview with Dr. Kenneth Liegner, MDDr. Kenneth Liegner is a Board Certified Internist with additional training in Pathology and Critical Care Medicine, practicing in Pawling, New York. He has been actively involved in diagnosis and treatment of Lyme disease and related disorders since 1988.

He has published articles on Lyme disease in peer-reviewed scientific journals and has presented poster abstracts and talks at national and international conferences on Lyme disease and other tick-borne diseases. He has cared for many persons seriously ill with chronic and neurologic Lyme disease. His work has focused on the serious morbidity and (occasional) mortality that can eventuate from this aspect of the illness. He has emphasized the urgent need for widespread clinical availability of improved methods of diagnostic testing and for development of improved methods of treatment for Lyme disease in all its stages. He holds the first United States patent issued proposing application of acaricide to deer for area-wide control of deer-tick populations as a means of reducing the incidence of Lyme disease. He has authored In the Crucible of Chronic Lyme Disease – Collected Writings & Associated Materials, a documentational history of the struggle to characterize the nature of Lyme disease in the late 20th and early 21st centuries, published November 2015.

He served two terms on the Board of Directors of the International Lyme and Associated Diseases Society (ILADS), is on the Scientific Advisory Board of the Lyme Disease Association, Inc, and is on the Medical Advisory Board of the Global Lyme Alliance. He is a member of The American Association of Physicians and Surgeons.

He was the first physician to apply disulfiram in the treatment of Lyme disease and published his experience with his first three patients in the peer-reviewed journal Antibiotics, May 2019.

He was co-author on a landmark pathologic study of tissues from a person with chronic Lyme disease and co-author of the ILADS evidence-based definition of chronic Lyme disease.

This May Awareness Guest Blog delves into the intricacies of Lyme disease with Kenneth Liegner, MD, a Board Certified Internist with specialized training in Pathology and Critical Care Medicine. In this interview, Dr. Liegner shares his journey into the world of Lyme disease, its evolving treatment, and his ongoing efforts to improve diagnostic methods and therapeutic solutions. He discusses the critical role of thinking holistically, patient advocacy, and the importance of organizations such as the Lyme Disease Association, Inc. in raising awareness and funding research. Dr. Liegner offers valuable insights and reflections on tackling one of the most challenging and misunderstood diseases of our time.

An Interview with Kenneth Liegner, MD

1. How did you get interested in specializing in Lyme and tick-borne diseases?

I started a solo private office-based practice of internal medicine in Armonk, NY with some critical care at the local hospital (Northern Westchester Hospital, Mt. Kisco, NY) around 1985. Unbeknownst to me at the time, northern Westchester was becoming a ‘hot-bed’ of Lyme disease and some of the earliest cases of Lyme meningitis were diagnosed there. I knew virtually nothing about Lyme disease at the time, other than the name and the story of its discovery by Allen Steere in Lyme, CT. Then I began seeing cases of the illness, which, really no clinician in Westchester could avoid. I found them extremely puzzling and challenging. They didn’t behave the way they were supposed to!  Symptoms would keep coming back despite application of ‘recommended’ antibiotic treatments. Gradually, through trial and error, I found it was necessary to extend the duration of treatment: first doubled, then later on tripled, quadrupled and finally, for some, adopted a somewhat ‘open-ended’ (not necessarily never-ending) approach.  In the early 1990s, there was a very convivial and collaborative approach between clinicians and academicians and everyone was excited to be learning about this new disease.

Things changed dramatically with the 1995 Dearborn conference and the roll-out of the Lyme vaccine, LYMErix, following which a very rigid ‘construct’ of Lyme disease was promoted as dogma. This had not previously been the case. Care for persons with Lyme disease was a ‘niche’ needing to be filled, and I filled it. My background in critical care (and anatomic pathology) was very suitable for grappling with a multi-system illness that required thinking holistically about the entire organism/person and not just isolated ‘organ systems’ into which many of the sub-specialties and sub-specialists in medicine were ‘siloed’. I was fortunate to be able to collaborate with many of the finest researchers in both academia and at CDC & NIH resulting in publication of some important abstracts and papers. This was very gratifying and intellectually stimulating. There was a sense of community and shared effort at the time.

2. What do you see as the biggest difference(s) from when you began focusing on Lyme and where we are today?

I started practice towards the end of the so-called ‘Golden Age’ of Medicine. A time when private practice was prevalent, physicians worked for the patient and the Hippocratic Oath was revered. Paul Starr accurately predicted the ‘coming of the corporation’ in his excellent book, The Social Transformation of American Medicine.  The advent of the hospitalist system also dramatically changed the nature of hospital medicine, where primary physicians no longer followed their patients in the hospital, guiding their care, watching out for their best interests and arranging optimal consultations. This served insurance company and hospital CEO corporate interests, enabling ‘efficiencies’ of care and a higher throughput, but completely broached often decades-long doctor-patient relationships. Hierarchical structures in hospital systems, including Pharmacy & Therapeutics Committees, helps explain why it remains, to this day, so difficult for persons with Lyme and tick-borne diseases to get personalized care within the hospital setting as well as within vertically-integrated corporate healthcare settings.

3. What are you most excited about in today’s treatment and/or hope for Lyme and other tick-borne diseases?

There is growing awareness of the complexity of tick- and vector-borne diseases. Meticulous scientific studies at the bench-level, with animal studies and also in clinical reports, elucidate a range of mechanisms that may be operative in maintaining illness. This raises consideration of novel interventions to improve people’s quality of life, which is paramount. Stalwart efforts by the patient community has resulted in government recognition that far greater financial and scientific resources are needed in this field.  Recalcitrant refusal to acknowledge the important role of persistent borrelial infection despite prior application of antibiotic treatment is frustrating and impedes progress in devising solutions. Despite some improved funding, a much greater level is needed.

4. Why is it important for LDA and other nonprofits to increase awareness for Lyme disease and other tick-borne illnesses?

Many medical, scientific, and societal problems vie for attention and compete for government resources. The voice of patients expressed individually and through patient advocacy and educational organizations to their legislative representatives at local, state, and national levels is extremely important. Due to limited government resources, not all investigators are able to secure grants or funding even when their work is highly meritorious. There remains an important role for private funding of research.

5. Please share any past reflections or your experiences with the LDA. . .

The LDA has held annual scientific conferences of high quality for decades. Collaborations with academicians, various branches of the Federal and State governments as well as clinicians has raised awareness of and respect for concerns of patients and the public. LDA’s financial support of scientific research has enabled innumerable published peer-reviewed articles listed on PubMed, advancing medical knowledge, ultimately improving patient care. The volunteered efforts of Pat Smith and the support staff of the LDA and its affiliates represent the highest embodiment of ideals of service.

For more:

Category:

Activism, Lyme, Uncategorized

Wheelchair Bound CEO Walks After Lyme Disease Treatment

https://danielcameronmd.com/wheelchair-bound-ceo-regains-ability-to-walk-after-lyme-disease-treatment/

WHEELCHAIR-BOUND CEO REGAINS ABILITY TO WALK AFTER LYME DISEASE TREATMENT

walk-lyme-disease

Lyme arthritis is characterized by joint swelling lasting for weeks to months and potentially causing permanent joint damage. It can worsen symptoms in patients with existing joint conditions such as osteoarthritis and may go undiagnosed, leading to unnecessary surgeries.

By 

In this case report, “Exacerbation of Osteoarthritic Joint Pain by Lyme Disease,” Bennani and colleagues demonstrate the importance in identifying an underlying tick-borne infection, as appropriate treatment can dramatically improve a patient’s quality of life.¹

A 63-year-old man, who was wheelchair-bound, presented to his clinician’s office with severe pain in both knees, which had been progressively worsening over several months.  He had previously undergone bilateral knee arthroscopies for meniscal tears and recently received corticosteroid injections, which did not alleviate his pain.

The authors suggest that while corticosteroids can reduce inflammation and alleviate pain, the bacterial infection can continue to proliferate and destroy knee tissue.

“Before treatment, our patient was wheelchair-bound due to the combination of existing osteoarthritis and the manifestation of Lyme disease in his knees.”

“The patient did report that he was recently on erythromycin for an upper respiratory infection (URI) and indicated that his knees felt better while he was taking erythromycin,” the authors state.

Furthermore, the patient, who worked as a chief executive officer (CEO) of a company, was an avid hunter and reported that his dog had Lyme disease.

Given that the patient’s dog had Lyme disease, Lyme IgG and Lyme IgM studies were ordered.

Testing for Lyme disease was positive and the patient began treatment with doxycycline.

“Upon completion of doxycycline therapy, our patient noted significant improvement in his knee pain,” the authors state.

His improvement was so significant that the patient no longer needed the use of a wheelchair and was able to cancel his bilateral knee replacement surgery.

Authors conclude: 

  • “Our patient was able to avoid a costly, high-risk surgical procedure with the detection and treatment of his Lyme disease.”
  • “Lyme disease should always be a consideration in the differential diagnosis of patients who have lived or have traveled to areas that are endemic to the disease and who tend to have outdoor lifestyles.”
Related Articles:

Successful treatment for Lyme arthritis after knee surgery
Borrelia burgdorferi causes prosthetic joint infection
Lyme arthritis and periprosthetic joint infections

References:
  1. Bennani A Z, Chegwidden B, Lambroussis C G, et al. (April 29, 2024) Exacerbation of Osteoarthritic Joint Pain by Lyme Disease. Cureus 16(4): e59318. doi:10.7759/cureus.59318

_______________

**Comment**

The first thing my mind said to this was duh!  Of course the man felt extremely better when being on erythromycin!  But, alas, this is where we are in 2024 – after 40 years of mythology about tick-borne illness.

Nothing’s changed.

If you want real help, you must go outside the mainstream medicine (MSM) paradigm, and get to a Lyme literate doctor (LLMD) even though MSM still calls them quacks.

A few important points:

  • He’s an avid hunter and is outside.  This raises the risk for tick-borne infections but you can still get infected in your own backyard.
  • His dog has Lyme.  This happened in our family as well.  Dogs are sentinels and a warning shot over the bow.  Testing for animals appears to be much better than for people and if your pet is infected – be on guard.  Estimates for Lyme based on canine models and human seroprevalence data is far higher than ‘official’ data.
  • While corticosteroids are loved by doctors for reducing inflammation and pain, they are a double-edged sword for patients who are infected.  Since they dampen the immune system they allow infections to worsen which is why identifying underlying infections is imperative.
  • I’m sorry but by NOW, if a patient improves while on antibiotics, the FIRST thing they should consider is tick-borne infections.  I mean really, this nonsense has gone on for far too long.
  • This man was lucky in that he tested positive.  What about the sorry suckers who don’t?  I’ll tell you what happens – they are kicked to the curb and allowed to languish for years and years and years until their lives are destroyed and it kills them.  Not a very happy ending but it’s happening to thousands upon thousands.
  • Notice the miraculous turn around of this patient.  This often happens – but sometimes it doesn’t because the WRONG treatment is used and it’s a different pathogen to blame.  There is nuance to treating this and MSM is woefully uneducated and unprepared.  Run away from MSM as fast as you can and get to someone who knows what they are doing.  I’m serious.  Don’t mess around with this.  You will thank me later.

For more:

Category:

Inflammation, Lyme, Pain Management, research, Testing